Gelonghui, December 27丨An investor asked Intel Group (000411.SZ) on the investor interactive platform, “Please ask if the development status of your cross-border e-commerce business will be beneficial to the company's development.” The company replied that the company's cross-border e-commerce business is mainly based on Intex International Pharmaceuticals. Currently, it is in its infancy and sales are not large.
英特集团(000411.SZ)：跨境电商业务以英特国际药业为主体，目前处于起步发展阶段
Intel Group (000411.SZ): The cross-border e-commerce business is dominated by Inter International Pharmaceuticals and is currently in the initial development stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.